Peter Bytzer

Peter Bytzer

Viceinstitutleder, Professor emeritus, Professor Emeritus

Medlem af:

  • Intern medicin: gastroenterologi og hepatologi


  1. 2017
  2. Udgivet

    Letter: bias in clinical trials of the symptomatic effects of the low FODMAP diet for irritable bowel syndrome-getting the facts right. Authors' reply

    Krogsgaard, L. R., Lyngesen, M. & Bytzer, Peter, 2017, I: Alimentary Pharmacology and Therapeutics. 46, 3, s. 386-387

    Publikation: Bidrag til tidsskriftKommentar/debatForskning

  3. Udgivet

    Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication

    Semb, S., Helgstrand, Frederik, Hjørne, F. & Bytzer, Peter, 2017, I: World Journal of Gastroenterology. 23, 37, s. 6907-6910

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  4. Udgivet

    Psychometric evaluation of a daily gastro-oesophageal reflux disease symptom measure

    Bytzer, Peter, Reimer, C., Smith, G., Anatchkova, M. D., Hsieh, R., Wilkinson, J., Thomas, S. J. & Lenderking, W. R., 2017, I: Scandinavian Journal of Gastroenterology. 52, 3, s. 276-283 8 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  5. Udgivet

    Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms

    Coyle, C., Crawford, G., Wilkinson, J., Thomas, S. J. & Bytzer, Peter, 2017, I: Alimentary Pharmacology and Therapeutics. 45, 12, s. 1524-1533

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  6. Udgivet

    Systematic review: quality of trials on the symptomatic effects of the low FODMAP diet for irritable bowel syndrome

    Krogsgaard, L. R., Lyngesen, M. & Bytzer, Peter, 2017, I: Alimentary Pharmacology and Therapeutics. 45, 12, s. 1506-1513

    Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

  7. 2016
  8. Udgivet

    Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota

    Elison, E., Vigsnæs, L. K., Krogsgaard, L. R., Rasmussen, J., Sørensen, N., McConnell, B., Hennet, T., Sommer, M. O. A. & Bytzer, Peter, okt. 2016, I: Nutrition Research Reviews. 116, 8, s. 1356-1368 13 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  9. Udgivet

    Letter: add-on alginate therapy for refluxpatients with inadequate response to aonce daily proton pump inhibitor – morequestions than answers. Authors’ reply

    Bytzer, Peter & Reimer, C., jul. 2016, I: Alimentary Pharmacology and Therapeutics. 44, 2, s. 208 1 s.

    Publikation: Bidrag til tidsskriftKommentar/debatForskning

  10. Udgivet

    Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add-on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor

    Reimer, C., Lødrup, A., Smith, G., Wilkinson, J. & Bytzer, Peter, apr. 2016, I: Alimentary Pharmacology and Therapeutics. 43, 8, s. 899-909

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  11. 2015
  12. Udgivet

    PMD34 A Novel Ibs Diagnostic Blood Panel Can Enhance A Positive Diagnostic Strategy Versus A Strategy Of Exclusion For Patients With Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D): Cost Implications For Denmark

    Purdy, C., Bytzer, Peter, Pimentel, M. M. & Magar, R., nov. 2015, I: Value in Health. 18, 7, s. A350

    Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningfagfællebedømt

  13. Udgivet

    Editorial: anti-secretory therapy prior to anti-reflux surgery. Does dose matter? Authors' reply

    Lødrup, A., Pottegård, A., Hallas, J. & Bytzer, Peter, sep. 2015, I: Alimentary Pharmacology and Therapeutics. 42, 5, s. 627-627 1 s.

    Publikation: Bidrag til tidsskriftLederForskningfagfællebedømt

ID: 547129